Sec. 202. GAO study and report on Medicare and Medicaid beneficiary access for vaccines
375 words·~2 min read·
/bill/114/hr/786/ih/section-202A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
The Comptroller General of the United States (in this section referred to as the Comptroller General ) shall conduct a study on the impact of reimbursement rates under the Medicare program under parts B, C, and D of title XVIII of the Social Security Act and under the Medicaid program under title XIX of such Act on access by targeted individuals to vaccines recommended by the Advisory Committee on Immunization Practices of the Centers for Disease Control and Prevention. Such study shall include an analysis and determination of— the reimbursement rates for vaccines under such parts of the Medicare program and under the Medicaid program, including those rates paid by a PDP sponsor under part D of title XVIII of such Act, Medicare Advantage organizations under part C of such title, and Medicaid managed care organizations (as defined in section 1903(m)(1)(A) of the Social Security Act ( 42 U.S.C. 1396b(m)(1)(A) ); the number of targeted individuals during the 3-year period prior to the study who were eligible for a vaccination recommended by the Advisory Committee on Immunization Practices of the Centers for Disease Control and Prevention; the number of such targeted individuals who actually received a vaccination described in paragraph (2), with a particular breakdown of adults, the elderly, and populations located in rural or underserved communities; and the extent to which the reimbursement rates under such parts of the Medicare program and under the Medicaid program for vaccinations described in paragraph
(2)affect their use by physicians or access for such targeted individuals. For purposes of subsection (a), the term targeted individual means and individual who is— entitled to benefits under part A of title XVIII of the Social Security Act or enrolled in part B of such Act; or eligible for medical assistance under title XIX of such Act; and within a vulnerable population. Not later than 2 years after the date of enactment of this Act, the Comptroller General shall submit to the appropriate committees of the Congress a report containing the results of the study conducted under subsection (a), including— a summary of the findings of the study; and recommendations based on the results of the study, including recommendations for such legislative and administrative action as the Comptroller General determines appropriate.
Connectionstraces to 1
Traces to 1 document
U.S. Code
Citation graph
cites case law
Sec. 202
GAO study and report on Medicare and Medicaid beneficiary access for vaccines
Cites 1Cited by 0 across 0 sources